ABSTRACT
BACKGROUND: Systemic sclerosis (SSc) is a rare chronic autoimmune disease with heterogeneous manifestations. In the last decade, several clinical trials have been conducted to evaluate new treatment options for SSc. The purpose of this work is to update the recommendations of the Brazilian Society of Rheumatology in light of the new evidence available for the pharmacological management of SSc. METHODS: A systematic review including randomized clinical trials (RCTs) for predefined questions that were elaborated according to the Patient/Population, Intervention, Comparison, and Outcomes (PICO) strategy was conducted. The rating of the available evidence was performed according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. To become a recommendation, at least 75% agreement of the voting panel was needed. RESULTS: Six recommendations were elaborated regarding the pharmacological treatment of Raynaud's phenomenon, the treatment (healing) and prevention of digital ulcers, skin involvement, interstitial lung disease (ILD) and gastrointestinal involvement in SSc patients based on results available from RCTs. New drugs, such as rituximab, were included as therapeutic options for skin involvement, and rituximab, tocilizumab and nintedanib were included as therapeutic options for ILD. Recommendations for the pharmacological treatment of scleroderma renal crisis and musculoskeletal involvement were elaborated based on the expert opinion of the voting panel, as no placebo-controlled RCTs were found. CONCLUSION: These guidelines updated and incorporated new treatment options for the management of SSc based on evidence from the literature and expert opinion regarding SSc, providing support for decision-making in clinical practice.
Subject(s)
Raynaud Disease , Rheumatology , Scleroderma, Systemic , Scleroderma, Systemic/complications , Scleroderma, Systemic/drug therapy , Humans , Brazil , Rheumatology/standards , Raynaud Disease/drug therapy , Societies, Medical , Lung Diseases, Interstitial/drug therapy , Antibodies, Monoclonal, Humanized/therapeutic use , Rituximab/therapeutic use , Randomized Controlled Trials as Topic , Skin Ulcer/etiology , Antirheumatic Agents/therapeutic useABSTRACT
Objetivo: Identificar la producción de conocimiento sobre el tratamiento de infecciones localizadas en heridas de difícil cicatrización. Método: Revisión integrativa de la literatura realizada en la Biblioteca Virtual en Salud; Base de datos de enfermería; Scientific Electronic Library; Web of Science; Biblioteca Cochrane; Catálogo de Tesis y Disertaciones de la Coordinación para el Perfeccionamiento del Personal de Educación Superior; y PubMed. Los artículos seleccionados no tienen límite de tiempo. Los estudios fueron exportados a la aplicación Rayyan y sometidos a evaluación doble ciego mediante la lectura del título y el resumen, según los criterios de inclusión y exclusión. La información fue analizada y sintetizada según el nivel de evidencia. Resultados: 19 estudios fueron incluidos para lectura completa. Se encontró como evidencia la higiene de la herida; la limpieza con ácido acético al 1%; la identificación y el tratamiento de biopelículas; el uso de cobertores y soluciones con acción antimicrobiana. Conclusión: La infección localizada de la herida ha sido objeto de varias investigaciones y las prácticas recomendadas se refieren a tratamientos tópicos. (AU)
Objective: To identify the knowledge production on the treatment of localized infections in hard-to-heal wounds. Method: An integrative literature review was conducted in the Virtual Health Library, Nursing Database, Scientific Electronic Library Online, Web of Science, Cochrane Library, Catalog of Theses and Dissertations of the Coordination for the Improvement of Higher Education Personnel, and PubMed. The selected articles had no time limit. The studies were exported to the Rayyan application and subjected to double-blind evaluation through title and abstract reading, based on inclusion and exclusion criteria. The information was analyzed and synthesized according to the level of evidence. Results: A total of 19 publications were fully analyzed. The evidence obtained on the topic includes wound hygiene, cleaning with 1% acetic acid, identification and treatment of biofilms, the use of dressings, and solutions with antimicrobial action. Conclusion: Localized wound infections have been the subject of various research studies, and the recommended practices refer to topical treatments. (AU)
Objetivo: Identificar a produção de conhecimento sobre o tratamento de infecções localizadas em feridas de difícil cicatrização. Método: Revisão integrativa da literatura realizada na Biblioteca Virtual em Saúde, Base de Dados de Enfermagem, Scientific Electronic Library Online, Web of Science, Biblioteca Cochrane, Catálogo de Teses e Dissertações da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior e Public Medline. Os artigos selecionados não possuem limite temporal. Os estudos foram exportados para o aplicativo Rayyan e submetidos à avaliação duplo-cega por meio da leitura do título e do resumo, com base nos critérios de inclusão e exclusão. As informações foram analisadas e sintetizadas de acordo com o nível de evidência. Resultados: Foram analisadas 19 publicações em sua totalidade. Obteve-se como evidências acerca do tema a higienização da ferida, a limpeza com ácido acético 1%, a identificação e o tratamento de biofilmes, o uso de coberturas e as soluções com ação antimicrobiana. Conclusão: A infecção localizada de feridas tem sido objeto de várias pesquisas e as práticas recomendadas referem-se a tratamentos tópicos. (AU)
Subject(s)
Humans , Skin Ulcer , Infections , Wounds and InjuriesABSTRACT
In this present study, carried out between November 2020 and July 2023 at Londrina's University Hospital, patients with active lesions of cutaneous leishmaniasis (CL) were analyzed regarding pain perception and anatomopathological aspects of the ulcers. Pain was assessed using a numerical rating scale (NRS) to compare five patients diagnosed with CL with four control patients diagnosed with vascular skin ulcers. Histopathological evaluations were used to investigate the nociceptor neuron-Leishmania interface. Patients with CL ulcers reported less pain compared to patients with vascular ulcers (2.60 ± 2.30 and 7.25 ± 0.95, respectively, p = 0.0072). Histopathology evidenced Leishmania spp. amastigote forms nearby sensory nerve fibers in profound dermis. Schwann cells marker (S100 protein) was detected, and caspase-3 activation was not evidenced in the in the nerve fibers of CL patients' samples, suggesting absence of apoptotic activity in nerve endings. Additionally, samples taken from the active edge of the lesion were negative for bacilli acid-alcohol resistant (BAAR), which excludes concomitant leprosy, in which painless lesions are also observed. Thus, the present data unveil for the first time anatomopathological and microbiological details of painless ulcers in CL patients, which has important clinical implications for a better understanding on the intriguing painless clinical characteristic of CL.
Subject(s)
Apoptosis , Leishmania , Leishmaniasis, Cutaneous , Skin Ulcer , Humans , Male , Female , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/parasitology , Adult , Middle Aged , Skin Ulcer/parasitology , Skin Ulcer/pathology , Sensory Receptor Cells/pathology , Neurons/pathology , Aged , Skin/parasitology , Skin/pathology , Skin/innervationABSTRACT
Cartilage hypoplasia syndrome is a primary immunodeficiency disease characterized by short stature, hypoplastic hair and a variable degree of immunodeficiency. Noninfectious cutaneous granulomas represent an uncommon yet well-recognized manifestation within the spectrum of primary immunodeficiency diseases. However, cutaneous granulomas as a manifestation of cartilage-hair hypoplasia syndrome, are extremely rare. We present a case of a middle-aged man with cartilage hypoplasia syndrome featuring cutaneous granulomas, manifesting as chronic, extensive and deep cutaneous ulcers. The patient was treated with anti-TNF-alpha adalimumab with partial improvement. Our case underscores the broad spectrum of clinical manifestations associated with cartilage hypoplasia syndrome and adds new evidence to the potential therapeutic efficacy of anti-TNF-alpha drugs in its treatment.
Subject(s)
Adalimumab , Granuloma , Hair , Osteochondrodysplasias , Primary Immunodeficiency Diseases , Skin Ulcer , Humans , Male , Hair/abnormalities , Primary Immunodeficiency Diseases/complications , Primary Immunodeficiency Diseases/diagnosis , Adalimumab/therapeutic use , Skin Ulcer/etiology , Skin Ulcer/drug therapy , Granuloma/drug therapy , Osteochondrodysplasias/complications , Osteochondrodysplasias/diagnosis , Osteochondrodysplasias/congenital , Hirschsprung Disease/complications , Hirschsprung Disease/diagnosis , Middle Aged , Hypotrichosis/diagnosisABSTRACT
Chronic ulcers significantly affect the quality of life of patients and impose a high cost on the healthcare system. The therapeutic management should be comprehensive, taking into consideration the etiological diagnosis of the wound and the characteristics of the wound bed when deciding on a therapeutic proposal appropriate to the healing phase, correcting factors that delay healing. During the epithelialization phase, repair techniques with grafts are recommended to shorten re-epithelialization time, improve the quality of scar tissue, and achieve adequate pain management. Currently, due to the reported benefits of skin appendages, the technique of follicular unit auto-grafting obtained with a scalp punch is among the chosen strategies for wound repair. This is a minimally invasive, outpatient practice, whose technique has advantages over the donor site, patients recovery and well-being.
Subject(s)
Wound Healing , Humans , Chronic Disease , Wound Healing/physiology , Hair Follicle/transplantation , Transplantation, Autologous , Skin Transplantation/methods , Skin Ulcer/surgery , Treatment Outcome , Quality of LifeABSTRACT
Cutaneous Leishmaniasis (CL) is a tropical disease characterized by cutaneous ulcers, sometimes with satellite lesions and nodular lymphangitis. Leishmania parasites, transmitted by sandfly vectors, cause this widespread public health challenge affecting millions worldwide. CL's complexity stems from diverse Leishmania species and intricate host interactions. Therefore, this study aims to shed light on the spatial-temporal distribution of Leishmania species and exploring the influence of skin microbiota on disease progression. We analyzed 40 samples from CL patients at three military bases across Colombia. Using Oxford Nanopore's Heat Shock Protein 70 sequencing, we identified Leishmania species and profiled microbiota in CL lesions and corresponding healthy limbs. Illumina sequencing of 16S-rRNA and 18S-rRNA genes helped analyze prokaryotic and eukaryotic communities. Our research uncovered a spatial-temporal overlap between regions of high CL incidence and our sampling locations, indicating the coexistence of various Leishmania species. L. naiffi emerged as a noteworthy discovery. In addition, our study delved into the changes in skin microbiota associated with CL lesions sampled by scraping compared with healthy skin sampled by brushing of upper and lower limbs. We observed alterations in microbial diversity, both in prokaryotic and eukaryotic communities, within the lesioned areas, signifying the potential role of microbiota in CL pathogenesis. The significant increase in specific bacterial families, such as Staphylococcaceae and Streptococcaceae, within CL lesions indicates their contribution to local inflammation. In essence, our study contributes to the ongoing research into CL, highlighting the need for a multifaceted approach to decipher the intricate interactions between Leishmaniasis and the skin microbiota.
Subject(s)
Leishmania , Leishmaniasis, Cutaneous , Psychodidae , Skin Ulcer , Animals , Humans , Leishmaniasis, Cutaneous/epidemiology , Leishmania/genetics , Skin/pathology , Psychodidae/parasitologyABSTRACT
BACKGROUND: Cutaneous melanoma is characterized by a high risk of metastasis to distant organs and a substantial mortality rate. For planning treatment and assessing outcomes, the Breslow micrometric measurement is critical. The tumor macroscopic dimension is not considered a prognostic parameter in cutaneous melanoma, although there are studies showing that tumor size is an independent prognostic factor for melanoma-specific survival. Therefore, this study aimed to evaluate the macroscopic dimension of melanoma and other known prognostic factors (i.e., Breslow index, mitoses, regression, and ulceration) as predictors of sentinel lymph node outcome and survival outcome. METHODS: We performed a retrospective cross-sectional study of 227 melanoma lesions subjected to sentinel lymph node biopsy at two Brazilian referral centers. RESULTS: On univariate analysis, there was a statistically significant correlation between the largest macroscopic tumor dimension and the sentinel lymph node result (P = 0.001); however, on multivariate analysis considering all evaluated parameters, there was no significant difference between the sentinel lymph node result and the tumor macroscopic dimension (P = 0.2689). Regarding melanoma-specific survival, the macroscopic dimension showed no significant correlation (P = 0.4632) in contrast to Breslow's dimension (P < 0.0001). CONCLUSION: The Breslow thickness was the only significant factor related to both the sentinel lymph node outcome and melanoma specific survival among the evaluated variables.
Subject(s)
Melanoma , Sentinel Lymph Node Biopsy , Skin Neoplasms , Tumor Burden , Humans , Melanoma/mortality , Melanoma/pathology , Melanoma/surgery , Skin Neoplasms/pathology , Skin Neoplasms/mortality , Skin Neoplasms/surgery , Male , Female , Retrospective Studies , Sentinel Lymph Node Biopsy/statistics & numerical data , Middle Aged , Aged , Cross-Sectional Studies , Adult , Prognosis , Lymphatic Metastasis/pathology , Aged, 80 and over , Sentinel Lymph Node/pathology , Mitotic Index , Survival Rate , Young Adult , Survival Analysis , Brazil/epidemiology , Skin Ulcer/pathology , Skin Ulcer/etiology , Skin Ulcer/mortality , Neoplasm StagingABSTRACT
Hoof diseases are a major welfare and economic issue in the global dairy cattle production industry, which can be minimized through improved management and breeding practices. Optimal genetic improvement of hoof health could benefit from a deep understanding of the genetic background and biological underpinning of indicators of hoof health. Therefore, the primary objectives of this study were to perform genome-wide association studies, using imputed high-density genetic markers data from North American Holstein cattle, for 8 hoof-related traits: digital dermatitis, sole ulcer, sole hemorrhage, white line lesion, heel horn erosion, interdigital dermatitis, interdigital hyperplasia, and toe ulcer, and a hoof health index. De-regressed estimated breeding values from 25,580 Holstein animals were used as pseudo-phenotypes for the association analyses. The genomic quality control, genotype phasing, and genotype imputation were performed using the PLINK (version 1.9), Eagle (version 2.4.1), and Minimac4 software, respectively. The functional genomic analyses were performed using the GALLO R package and the DAVID platform. We identified 22, 34, 14, 22, 28, 33, 24, 43, and 15 significant markers for digital dermatitis, heel horn erosion, interdigital dermatitis, interdigital hyperplasia, sole hemorrhage, sole ulcer, toe ulcer, white line lesion disease, and the hoof health index, respectively. The significant markers were located across all autosomes, except BTA10, BTA12, BTA20, BTA26, BTA27, and BTA28. Moreover, the genomic regions identified overlap with various previously reported quantitative trait loci for exterior, health, meat and carcass, milk, production, and reproduction traits. The enrichment analyses identified 44 significant gene ontology terms. These enriched genomic regions harbor various candidate genes previously associated with bone development, metabolism, and infectious and immunological diseases. These findings indicate that hoof health traits are highly polygenic and influenced by a wide range of biological processes.
Subject(s)
Cattle Diseases , Dermatitis , Digital Dermatitis , Foot Diseases , Foot Ulcer , Hoof and Claw , Skin Ulcer , Cattle/genetics , Animals , Foot Diseases/genetics , Foot Diseases/veterinary , Genome-Wide Association Study/veterinary , Digital Dermatitis/genetics , Ulcer/veterinary , Hyperplasia/veterinary , Cattle Diseases/genetics , Phenotype , Foot Ulcer/veterinary , Genomics , Dermatitis/veterinary , Hemorrhage/veterinary , North AmericaABSTRACT
A manifestação mais frequente da leishmaniose tegumentar (LT) é uma úlcera cutânea única, porém existem outras apresentações clínicas, menos comuns. Relatamos aqui uma manifestação rara de LT diagnosticada numa gestante de 37 anos que apresentava uma lesão infiltrativa e eritematosa no dorso nasal há três meses, de aspecto framboesiforme. Não se identificou nenhum acometimento de mucosas, mas a paciente queixava-se de dor e parestesia local. Não havia imunossupressão ou outras doenças associadas. Inicialmente tratada com anfotericina B, a paciente apresentou recidiva da doença depois de oito meses, optando-se por novo tratamento com antimonial pentavalente. Por ser uma forma atípica da LT, essa etiologia tardou a ser lembrada e consequentemente permitiu um atraso no tratamento, fato que reforça a importância de se incluir a LT no leque diferencial dos possíveis diagnósticos de quaisquer lesões de pele em áreas endêmicas
Subject(s)
Humans , Skin Ulcer/complications , Amphotericin B/therapeutic use , Leishmaniasis, Cutaneous/diagnosis , Meglumine Antimoniate , Meglumine Antimoniate/therapeutic useABSTRACT
ABSTRACT Objective: To map the nanocomposites used in the treatment of skin lesions. Method: A scoping review, according to the Joanna Briggs Institute methodology, carried out on eight databases, a list of references and Google Scholar to answer the question: "Which nanocomposites are used as a cover for the treatment of skin lesions?". Two independent reviewers selected the final sample using inclusion/exclusion criteria using the EndNote® and Rayyan programs. Data was extracted using an adapted form and reported using the PRISMA checklist extension, and the protocol was registered in the Open Science Framework (OSF). Results: 21 articles were selected, with nanofibers, nanogels and nanomembranes as the nanocomposites described in wound healing, alone or in association with other therapies: negative pressure and elastic. Silver nanomaterials stand out in accelerating healing due to their antimicrobial and anti-inflammatory action, but caution should be exercised due to the risk of cytotoxicity and microbial resistance. Conclusion: Nanocomposites used in wound treatment are effective in accelerating healing and reducing costs, and the addition of bioactives to nanomaterials has added extra properties that contribute to healing.
RESUMEN Objetivo: Mapear los nanocompuestos utilizados en el tratamiento de lesiones cutáneas. Método: Revisión de alcance, según la metodología del Instituto Joanna Briggs, realizada sobre ocho bases de datos, una lista de referencias y Google Scholar para responder a la pregunta: "¿Qué nanocompuestos se utilizan como cobertura para el tratamiento de lesiones cutáneas?". Dos revisores independientes seleccionaron la muestra final mediante criterios de inclusión/exclusión utilizando los programas EndNote® y Rayyan. Los datos se extrajeron mediante un formulario adaptado y se notificaron utilizando la extensión de la lista de comprobación PRISMA, y el protocolo se registró en el Open Science Framework (OSF). Resultados: Se seleccionaron 21 artículos, con nanofibras, nanogeles y nanomembranas como los nanocompuestos descritos en la cicatrización de heridas, solos o en asociación con otras terapias: presión negativa y elástica. Los nanomateriales con plata destacan en la aceleración de la cicatrización por su acción antimicrobiana y antiinflamatoria, pero se recomienda precaución en su uso por el riesgo de citotoxicidad y resistencia microbiana. Conclusión: Los nanocompuestos utilizados en el tratamiento de heridas son eficaces para acelerar la cicatrización y reducir costes, y la adición de bioactivos a los nanomateriales ha añadido propiedades adicionales que contribuyen a la cicatrización.
RESUMO Objetivo: Mapear os nanocompostos utilizados no tratamento de lesões cutâneas. Método: Revisão de escopo, conforme metodologia Joanna Briggs Institute, realizada em oito bases de dados, lista de referências e Google Scholar para responder à pergunta: "Quais os nanocompostos utilizados como cobertura para o tratamento de lesões cutâneas?". Dois revisores independentes, selecionaram a amostra final mediante critérios de inclusão/exclusão usando os programas EndNote® e Rayyan. Os dados foram extraídos com formulário adaptado e reportados pela extensão do checklist PRISMA, o protocolo foi registrado na Open Science Framework (OSF). Resultados: 21 artigos selecionados, trouxeram nanofibras, nanogéis e nanomembranas como os nanocompostos descritos na cicatrização de feridas, isolados ou em associação a outras terapias: pressão negativa e elástica. Os nanomateriais com prata destacam-se em acelerar a cicatrização pela ação antimicrobiana e anti-inflamatória, recomenda-se cautela no uso pelo risco de citotoxicidade e resistência microbiana. Conclusão: Os nanocompostos utilizados no tratamento de feridas são eficientes em acelerar a cicatrização e reduzir custos, a adição de bioativos aos nanomateriais agregaram propriedades extras que contribuem com a cicatrização.
Subject(s)
Humans , Pediatric Nursing , Wounds and Injuries , Nanocomposites , Skin UlcerABSTRACT
Background: Marjolin's ulcer is the malignant degeneration of any chronic wound, with a latency period from tissue injury to variable malignant transformation that may occur up to 30 years later. Among the associated neoplasms, squamous cell carcinoma (SCC) is the predominant lineage in up to 71% of cases. The verrucous carcinoma variant has been estimated to have a low presentation, being described in the literature as 2% of all SCC and reported anecdotally in immunosuppressed patients, which justifies the objective of this publication. Clinical case: 65-year-old female patient with a history of being a carrier of human immunodeficiency virus (HIV) infection, who presented a verrucous carcinoma associated to a Marjolin ulcer secondary to herpes zoster and infection of soft tissues in the right leg, with a latency period of 10 years from the initial infectious process to histopathological confirmation. Conclusions: The finding of a verrucous carcinoma on a Marjolin ulcer has been little described in literature, with a lower incidence in the context of a patient with a history of being a carrier of HIV infection, finding 7 case reports, the oldest from 1998. For this reason, it is important to have diagnostic suspicion, to carry out an adequate study protocol and always making clinical-pathological correlation, in order to establish timely and individualized treatment.
Introducción: la úlcera de Marjolin es la degeneración maligna de cualquier herida crónica, con un periodo de latencia desde la lesión tisular a la transformación maligna variable que puede presentarse hasta 30 años después. De las neoplasias asociadas, el carcinoma espinocelular es la estirpe predominante hasta en 71% de los casos. La variante de carcinoma verrugoso se ha estimado con una presentación baja, pues ha sido descrito en la literatura como el 2% de todos los carcinomas espinocelulares y reportado de manera anecdótica en pacientes inmunosuprimidos, lo que justifica el objetivo de esta publicación. Caso clínico: mujer de 65 años con el antecedente de ser portadora de infección por virus de inmunodeficiencia humana (VIH), que presentó un carcinoma verrugoso asociado a una úlcera de Marjolin secundaria a herpes zóster e infección de tejidos blandos en pierna derecha, con un periodo de latencia de 10 años desde el proceso infeccioso inicial hasta la confirmación histopatológica. Conclusiones: el hallazgo de un carcinoma verrugoso asentado sobre una úlcera de Marjolin ha sido poco descrito en la literatura, con una menor incidencia en el contexto de un paciente con antecedente de ser portador de infección por VIH, ante lo cual encontramos 7 reportes de caso, el más antiguo de 1998. Por este motivo es importante contar con la sospecha diagnóstica, para poder hacer un protocolo de estudio adecuado y siempre haciendo correlación clínico-patológica, con la finalidad de instaurar un tratamiento oportuno e individualizado.
Subject(s)
Carcinoma, Squamous Cell , Carcinoma, Verrucous , HIV Infections , Skin Neoplasms , Skin Ulcer , Female , Humans , Aged , Skin Neoplasms/complications , Skin Neoplasms/diagnosis , Ulcer/complications , Skin Ulcer/etiology , Skin Ulcer/pathology , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Verrucous/complications , Carcinoma, Verrucous/diagnosis , Immunocompromised HostABSTRACT
Cutaneous leishmaniasis (CL) is a neglected disease caused by an intracellular parasite of the Leishmania genus. CL lacks tools that allow its understanding and treatment follow-up. This article presents the use of metrical and optical tools for the analysis of the temporal evolution of treated skin ulcers caused by CL in an animal model. Leishmania braziliensis and L. panamensis were experimentally inoculated in golden hamsters, which were treated with experimental and commercial drugs. The temporal evolution was monitored by means of ulcers' surface areas, as well as absorption and scattering optical parameters. Ulcers' surface areas were obtained via photogrammetry, which is a procedure that allowed for 3D modeling of the ulcer using specialized software. Optical parameters were obtained from a spectroscopy study, representing the cutaneous tissue's biological components. A one-way ANOVA analysis was conducted to identify relationships between both the ulcers' areas and optical parameters. As a result, ulcers' surface areas were found to be related to the following optical parameters: epidermis thickness, collagen, keratinocytes, volume-fraction of blood, and oxygen saturation. This study is a proof of concept that shows that optical parameters could be associated with metrical ones, giving a more reliable concept during the assessment of a skin ulcer's healing.
Subject(s)
Leishmaniasis, Cutaneous , Skin Ulcer , Cricetinae , Animals , Ulcer , Leishmaniasis, Cutaneous/drug therapy , Skin , Skin Ulcer/drug therapy , Skin Ulcer/parasitology , Mesocricetus , Disease Models, AnimalABSTRACT
Propolis is a natural resin that is produced by bees. It has anti-inflammatory and antibiotic properties, promotes reepithelization, and stimulates skin regeneration. Propolis has great potential for the development of new therapeutic approaches to treat skin ulcers. The present study performed a systematic review and meta-analysis of published studies of the use of propolis for the regeneration of cutaneous wounds and its efficacy as a therapeutic agent. Data were collected from articles in the PubMed, SCOPUS, and Web of Science databases that were published since 1900 by searching the terms "propolis" AND "wound healing." This search yielded 633 articles, of which 43 were included in this systematic review and meta-analysis. The results showed that interest in the therapeutic efficacy of propolis has increased over the years. The studies reported that the propolis was effective for the treatment of skin ulcers by promoting a higher percentage of healing than classically employed interventions. The mode of propolis application has also evolved. An increasing number of studies combined it with other substances and materials to achieve additive or synergistic effects on the skin regeneration process. Propolis appears to be an effective therapeutic alternative for the treatment of skin ulcers.
Subject(s)
Propolis , Skin Ulcer , Humans , Propolis/therapeutic use , Skin , Wound Healing , Skin Ulcer/drug therapy , Anti-Bacterial Agents/therapeutic useABSTRACT
A cicatrização de úlceras cutâneas depende de fatores-chave que incluem a interação adequada dos diferentes constituintes celulares da epiderme, derme e tecido subcutâneo. A restauração da barreira epidérmica é altamente eficiente durante o período embrionário, com um relativo decréscimo na vida adulta. Distúrbios sistêmicos, como diabetes e hanseníase, podem comprometer a capacidade de reparação da pele, gerando ulceras crônicas, que são consideradas como relevantes problemas de saúde pública. O presente estudo se propôs a estabelecer parâmetros de eficiência de membranas bioativas, preparadas com o biopolímero quitosana (QT), em associação ao extrato vegetal, madecassoside (MA). Nas preparações obtidas, foram avaliadas características físico-químicas e propriedades antimicrobianas. A biocompatibilidade das preparações, e sua capacidade de promover migração celular, foi testada in vitro em fibroblastos da linhagem NIH/3T3. As membranas foram divididas em grupos: QT 2%; QT/MA 0,10% (QTMA010); QT/MA 0,25% (QTMA025); QT/MA 0,50% (QTMA050). Os grupos foram avaliados em diferentes intervalos de tempo, de 0 a 96 horas (T0, T24, T48, T72, T96). Nossos dados indicam que membranas bioativas, preparadas com quitosana (QT 2%) e madecassoside (MA 0,10%, 0,25%, 0,50%), são biocompatíveis e possuem propriedades físico-químicas adequadas. As preparações contendo associação de ambos os compostos se mostraram superiores à QT. A capacidade de promover migração de fibroblastos, in vitro, foi estatisticamente superior em todos os grupos acrescidos de MA, indicando um papel relevante desse composto em preparações de utilização tópica para cicatrização úlceras cutâneas.
Subject(s)
Skin Ulcer/therapy , Wound Healing , Chitosan/therapeutic use , Skin/injuries , Biopolymers , In Vitro Techniques , Phytochemicals/therapeutic useABSTRACT
La histoplasmosis diseminada es una infección oportunista frecuente en los pacientes VIH/sida. Frecuentemente se encuentra compromiso cutáneo, siendo las formas clínicas más comunes el aspecto moluscoide, variceliforme y papulonecrótico.Se presenta el caso de una paciente con una forma cutánea atípica de histoplasmosis diseminada similar a pioderma gangrenoso cuyo diagnóstico fue realizado mediante escarificación.Es importante mantener la sospecha clínica en estas presentaciones atípicas y reforzar la utilidad de la escarificación de lesiones cutáneas como método rápido y efectivo para su diagnóstico.
Disseminated histoplasmosis is a frequent opportunistic infection in HIV/AIDS patients. Cutaneous manifestations are common, the most frequent are molluscum contagio-sum-like lesions, varicelliform eruption and papulo-necro-tic lesions.We present a case of an atypical disseminated cutaneous histoplasmosis with pyoderma gangrenosum-like ulcers, diagnosed by direct examination of tissue smear.It is important to have a high clinical suspicion of this atypical presentation and to emphasize the usefulness of skin smear as a simple and effective test to establish its diagnosis
Subject(s)
Humans , Female , Adult , Skin Ulcer , Opportunistic Infections/complications , HIV/immunology , Pyoderma Gangrenosum/diagnosis , Histoplasmosis/diagnosisABSTRACT
Infantile hemangiomas (IHs) are the most common benign tumors of childhood, and segmental ones are rare and associated with a poor prognosis. While these tumors look harmless, one of their main related complications is ulceration during tumor growth. The management in these cases is extremely challenging, requiring a combination of multiple approaches, some specifically aimed at preventing the proliferation of the hemangioma and others aimed at wound care, pain management, and prevention of further infection. Here we discuss two cases to narrate our experience on the management of this condition and its outcome.
Los hemangiomas infantiles (HI) son los tumores benignos más frecuentes de la infancia; la variante segmentaria es rara y se asocia con un mal pronóstico. Una de sus principales complicaciones es la ulceración durante la fase de crecimiento del tumor, a pesar de no presentar características macroscópicas compatibles con una lesión agresiva. El manejo en estos casos es dificultoso e impone la necesidad de asociar múltiples estrategias, algunas orientadas específicamente a impedir la proliferación del hemangioma y otras orientadas a la curación de la herida, el manejo del dolor y la prevención de la infección agregada. Presentamos dos casos a fin de comunicar nuestra experiencia respecto del manejo de dicha patología y su evolución final.
Subject(s)
Hemangioma , Skin Neoplasms , Skin Ulcer , Administration, Oral , Child , Hemangioma/complications , Hemangioma/drug therapy , Humans , Infant , Propranolol , Skin Neoplasms/drug therapy , Skin Ulcer/drug therapy , Skin Ulcer/etiology , Treatment Outcome , Ulcer/etiologyABSTRACT
Los hemangiomas infantiles (HI) son los tumores benignos más frecuentes de la infancia; la variante segmentaria es rara y se asocia con un mal pronóstico. Una de sus principales complicaciones es la ulceración durante la fase de crecimiento del tumor, a pesar de no presentar características macroscópicas compatibles con una lesión agresiva. El manejo en estos casos es dificultoso e impone la necesidad de asociar múltiples estrategias, algunas orientadas específicamente a impedir la proliferación del hemangioma y otras orientadas a la curación de la herida, el manejo del dolor y la prevención de la infección agregada. Presentamos dos casos a fin de comunicar nuestra experiencia respecto del manejo de dicha patología y su evolución final.
Infantile hemangiomas (IHs) are the most common benign tumors of childhood, and segmental ones are rare and associated with a poor prognosis. While these tumors look harmless, one of their main related complications is ulceration during tumor growth. The management in these cases is extremely challenging, requiring a combination of multiple approaches, some specifically aimed at preventing the proliferation of the hemangioma and others aimed at wound care, pain management, and prevention of further infection. Here we discuss two cases to narrate our experience on the management of this condition and its outcome.
Subject(s)
Humans , Female , Infant, Newborn , Skin Neoplasms/drug therapy , Skin Ulcer/etiology , Skin Ulcer/drug therapy , Hemangioma/complications , Propranolol , Ulcer/etiology , Administration, Oral , Treatment Outcome , Hemangioma/drug therapyABSTRACT
Leprosy is a neglected disease caused by Mycobacterium leprae and Mycobacterium lepromatosis, and is related to significant disabilities resulting from the neural damage generated by this mycobacteria. Neuropathic ulcers-lesions that can appear at the plantar and extra-plantar levels-are one such disability, and diagnosis requires an adequate dermatological, neurological and microbiological evaluation. The treatment of these lesions is based on a multidisciplinary approach that includes debridement of the necrotic tissue, controlling infections, reducing pressure areas, optimising blood flow, and nerve decompression. This review aims to describe the clinical features, diagnostic methods and treatment of neuropathic ulcers in leprosy. The diagnostic methods and medical management used in leprosy ulcers are based on those used for diabetic foot. This requires radical change as these diseases are immunologically and physiologically very different.